Supporting these findings are reports showing that CEBPA knockdown decreases Chaf1a expression, and that patients with acute myeloid leukemia that have CEBPA double mutations have decreased Chaf1a levels [41,46,47]. Here, CEBPA is linked to acute myeloid leukemia.